Summary of COVID-19 clinical practice adjustments across select institutions
Pediatr Blood Cancer
.
2020 Nov;67(11):e28411.
doi: 10.1002/pbc.28411.
Epub 2020 Jul 19.
Authors
Liora Schultz
1
,
Michael P Link
1
,
Susan Rheingold
2
,
Douglas S Hawkins
3
,
Jeffrey S Dome
4
,
Jonathan Wickiser
5
,
Andrew L Kung
6
,
Tara O Henderson
7
,
Catherine Aftandilian
1
Affiliations
1
Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
2
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
3
Seattle Children's Hospital, Seattle, Washington.
4
Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia.
5
UT Southwestern, Dallas, Texas.
6
Memorial Sloan Kettering Cancer Center, New York, New York.
7
University of Chicago Comer Children's Hospital, Chicago, Illinois.
PMID:
32779834
PMCID:
PMC7404360
DOI:
10.1002/pbc.28411
No abstract available
Publication types
Letter
MeSH terms
COVID-19 / epidemiology*
COVID-19 / immunology
Child
Humans
Immunocompromised Host
Neoplasms / epidemiology*
Neoplasms / immunology
Neoplasms / therapy
Pediatrics / standards*
Practice Guidelines as Topic*
SARS-CoV-2